Press Releases

Definium Therapeutics, Inc. (NASDAQ:DFTX) ("Definium" or the "Company"), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that members of the Company’s management team will participate in the following investor conferences and events: Stifel Hosted Webinar: Definium Therapeutics Virtual Fireside Chat Presentation Date and Time: Tuesday, September 1, 2026 at 1:00 PM ET Moderator: Paul Matteis, Head of Therapeutics Research Focus: Discussion of Definium’s positive topline results from the Phase 3 Voyage study of DT120 ODT in generalized anxiety

DUBLIN, Aug. 26, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (NASDAQ:JAZZ) ("Jazz Pharmaceuticals") today announced that Jazz Investments I Limited, its wholly-owned subsidiary (the "Issuer"), intends to offer, subject to market conditions and other factors, $1.0 billion aggregate principal amount of exchangeable senior notes due 2032 (the "notes") in a private offering (the "offering") to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The Issuer also intends to grant the initial purchasers of the notes the right to purchase, exercisable within a 13-day period from, and including the initial issue date of the notes,

SINGAPORE, Aug. 26, 2026 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE:LITB) ("LightInTheBox" or the "Company"), a global consumer lifestyle company, today announced its unaudited financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial HighlightsTotal Revenues were $56.8 million, a modest 4% decrease year over year, as the company optimized its product mix through phasing out long-tail products.Gross Profit was $37.6 million, compared with $38.8 million in the same quarter last year.Gross Margin was 66.1%, compared with 65.9% in the same quarter last year, which remained stable.Operating Expenses were $35.5 million, compared with $36.9 million in t

BRIDGEWATER, N.J., Aug. 26, 2026 /PRNewswire/ -- Insmed Incorporated (NASDAQ:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced that management will present at the following investor conferences:12th Annual Cantor Fitzgerald Global Healthcare Conference in New York City on Wednesday, September 9, 2026, at 8:00 a.m. ET.24th Annual Morgan Stanley Global Healthcare Conference in New York City on Monday, September 14, 2026, at 2:35 p.m. ET.These events will be webcasted live and can be accessed by visiting the investor relations section of the Company's website a

Orlando area is the location of Wayfair's 10th store as the company continues to expand its footprintBOSTON, Aug. 26, 2026 /PRNewswire/ -- Wayfair Inc. (NYSE:W), the destination for all things home, today announced a major milestone in the expansion of its stores, with plans to open its 10th Wayfair store in Altamonte Springs, Florida in 2028. The 85,000-square-foot, single level store at Marketplace at Altamonte will bring Wayfair's immersive, curated shopping experience to customers across the Central Florida region while marking the latest step in the company's growing omnichannel strategy. This new location brings Wayfair's

ORRVILLE, Ohio, Aug. 26, 2026 /PRNewswire/ -- The J.M. Smucker Co. (NYSE:SJM) today announced results for the first quarter ended July 31, 2026, of its 2027 fiscal year. All comparisons are to the first quarter of the prior fiscal year, unless otherwise noted.EXECUTIVE SUMMARYNet sales was $2.2 billion, an increase of $106.0 million, or 5 percent.Net income per diluted share was $3.03. Adjusted earnings per share was $3.24, an increase of 71 percent, which included an $0.84 benefit from tariff refunds received in the quarter.Cash provided by operating activities was $425.7 million compared to cash used for operating activities of $10.6 million in the prior year.Free cash flow was $337.3 mill

CHICAGO, Aug. 26, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced plans to launch financially-settled Wind Power futures and options in the fourth quarter, pending regulatory review. These new tools will help market participants manage risk associated with wind power generation, extending CME Group's suite of market-leading energy products. Based on indices provided by Vaisala Xweather, the new futures will track and settle against independent datasets that model projected wind power output at designated locations. The new contracts add to CME Group's market-leading product offerings that help customers navigate the energy transition, including He

Industry-first connected benefits experience helps people access cash benefits when they need it most and gives employers more affordable coverage optionsBLOOMFIELD, Conn., Aug. 26, 2026 /PRNewswire/ -- Cigna Healthcare®, the health benefits division of The Cigna Group (NYSE:CI), is introducing a new connected benefits experience that helps people pay for costs associated with unexpected or costly health events by bringing medical and supplemental health benefits together in a simpler, more personalized way.By linking medical and supplemental health benefits, the new solution reduces administrative complexity and helps customers identify and use their available benefits. It also makes it eas

CALGARY, AB, Aug. 26, 2026 /CNW/ -- Enbridge Inc. (Enbridge) (TSX:ENB) (NYSE:ENB) announced today that, through a wholly-owned subsidiary, it has entered into a definitive agreement to acquire Salt Creek Midstream's crude oil gathering business, comprising 100% of the Orla and Wink North systems and a 50% interest in the Delaware Crossing (DCX) system for cash consideration of US$600 million. The business includes approximately 500 miles of crude oil gathering infrastructure located in the core of the Delaware Basin, one of the most prolific and competitive crude oil producing regions in North America. The system serves a diversified group of more than 20 producers and is supported by approx

Bank to Report Third Quarter Fiscal 2026 Results Thursday, September 3, 2026 at 7:00 a.m. ETLONDON, ON, Aug. 26, 2026 /CNW/ -- VersaBank (or the "Bank") (TSX:VBNK) (NASDAQ:VBNK) will report its third quarter 2026 financial results and host a conference call to discuss those results on Thursday, September 3, 2026. The conference call/webcast is scheduled for 9:00 a.m. ET and is expected to last approximately 60 minutes. The conference call/webcast will include a presentation by David Taylor, President and Nicolas Ospina, Global CFO, followed by a question-and-answer period. The Bank will report its financial results via news release at approximately 7:00 a.m. ET.

Combined Solution Enables Aerial Platforms to Detect, Track and Engage Terrestrial and Maritime Targets, Pairing SwarmOS Edge-Based Perception, Collaboration, and Multi-Target Coordination with NORDA’s Combat-Proven SystemsPalladyne AI (NASDAQ:PDYN), a U.S.-based defense and industrial technology company delivering embodied AI-powered collaborative autonomy solutions, and NORDA Dynamics ("NORDA"), a Ukrainian-Estonian developer of a drone autonomy ecosystem proven in active combat, today announced a collaboration to integrate Palladyne AI’s SwarmOS™ decentralized, collaborative autonomy platform with the Underdog Autonomy Module, NORDA’s autonomous terminal guidance product for next-generati

Acquisition accelerates Perion’s In-Store Retail Media DOOH reach and expands Perion’s TAM within the $70B+ U.S. Retail Media Market Perion (NASDAQ & TASE: PERI), an advanced technology leader solving for the complexities of digital advertising through AI-native execution infrastructure, today announced it is accelerating its in-store media presence with the acquisition of PRN, a leading In-Store Retail Media company. The transaction amount is up to $12 million and is expected to be accretive from closing. Physical retail accounts for more than 80% of U.S. retail commerce, and in-store media inventory has become one of the most coveted components of major consumer brands’ media plans, r

Insulet Corporation (NASDAQ:PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the Wells Fargo 21st Annual Healthcare Conference in Boston on Wednesday, September 9, 2026, at 2:15 p.m. (Eastern Time). The live webcast and replay of the presentation will be accessible on the Insulet Investor Relations website: investors.insulet.com/events. About Insulet Corporation: Insulet Corporation (NASDAQ:PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnip

Entegris, Inc. (NASDAQ:ENTG), a global leader in advanced materials and purity solutions for the semiconductor industry, today announced it will hold its Investor Day for the investment community in New York City on Monday, November 9, 2026. The event will begin promptly at 1:00pm ET. Scheduled participants will include David Reeder, President and CEO, Sukhi Nagesh, SVP & CFO, as well as additional senior leadership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260825367776/en/ A webcast of the event can also be viewed live on our website at investor.entegris.com. ABOUT ENTEGRIS Entegris is a leading supplier of advanced m

Unlocking Precision and Safety in Autonomous Agriculture: GUSS Plans Deployment of Rev8 to Revolutionize Orchard Operations Ouster, Inc. (NASDAQ:OUST) ("Ouster" or the "Company"), a leader in sensing and perception for Physical AI, today announced that GUSS Automation, a wholly owned John Deere Subsidiary and a pioneer in autonomous high-value crop operations, plans to incorporate Ouster’s Rev8 OS0 native color digital lidar sensors, powered by the breakthrough L4 Ouster Silicon, into the next generation of its Autonomous Orchard Machine Fleet. The integration is expected to further expand machine capabilities while underscoring the role of advanced sensing technologies in helping autonom

BROOKFIELD, Conn., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Photronics, Inc. (NASDAQ:PLAB), a worldwide leader in photomask technologies and solutions, today reported financial results for its third quarter of fiscal year 2026 ended August 2, 2026. Commenting on the third quarter performance, Chairman and CEO George Macricostas said, "We are pleased to recognize a recovery of some of the temporarily delayed semiconductor design releases that occurred back in our fiscal Q2. Continued high fab utilization rates throughout the industry have been a positive influence toward node migration trends, resulting in a record percentage for our high-end I.C. business at 44% of total I.C. revenue. Our invest

SYDNEY, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX: RAD, NASDAQ:RADX, "Radiopharm" or the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today announced that it has dosed the first patient in the second cohort of its First-In-Human (FIH) Phase 1/2a clinical trial of RV-01 (177Lu-Betabart) in patients with B7-H3 expressing tumors. This follows a positive recommendation from the Safety and Monitoring Committee (SMC), an independent multidisciplinary committee, to advance to the 70 mCi dose of RV-01. RV-01 is a 177Lutetium-tagged engineered monoclonal antibody, des

MEXICO CITY, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Veea Inc. ("Veea") (NASDAQ:VEEA), a provider of AI-driven, cybersecure edge infrastructure, today announced that its VHC25 VeeaHub® has completed Total Play Telecomunicaciones’ ("Totalplay") technical qualification process, clearing a key milestone as the companies advance plans to offer Veea SecureConnect™ and VigiLynx™ to Totalplay business customers in Mexico. Veea and Totalplay have signed a collaboration agreement that provides a framework for combining Totalplay’s fiber connectivity and managed-services operations with Veea’s cloud-managed edge platform. Totalplay operates one of Mexico’s largest 100% fiber-optic networks and serves re

The first patient has been dosed in the TROPION-Urothelial04 phase 3 trial evaluating Datroway® (datopotamab deruxtecan) plus rilvegostomig or Datroway monotherapy versus current standard of care (durvalumab monotherapy or nivolumab monotherapy or enfortumab vedotin plus pembrolizumab) as an adjuvant treatment (after surgery) in patients with muscle invasive urothelial cancer (MIUC) at high risk of recurrence following radical surgical resection with or without prior neoadjuvant therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZe

ISFIYA, Israel, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ:MBAI), an embodied artificial intelligence company, announced today the pricing of its public offering of 1,538,462 Ordinary Shares at a public offering price of $6.50 per share, before underwriting discounts and commissions. In addition, the Company has granted the underwriter a 30-day option to purchase up to an additional 230,769 Ordinary Shares at the public offering price, less the underwriting discounts and commissions. The offering is expected to close on or about August 27, 2026, subject to the satisfaction of customary closing conditions. The gross proceeds to the Company from